1: Principles of Pharmacology
2: Structure and Function of the Nervous System
3: Chemical Signaling by Neurotransmitters and Hormones
4: Methods of Research in Psychopharmacology
8: Glutamate and GABA
9: Drug Abuse and Addiction
11: The Opioids
12: Psychomotor Stimulants: Cocaine and the Amphetamines
13: Nicotine and Caffeine
14: Marijuana and the Cannabinoids
15: Hallucinogens, PCP, and Ketamine
16: Inhalants, GHB, and Anabolic-Androgenic Steroids
17: Environmental Neurotoxicants and Endocrine Disruptors
18: Anxiety Disorders: Sedative-Hypnotic and Anxiolytic Drugs
19: Affective Disorders: Antidepressants and Mood Stabilizers
20: Schizophrenia: Antipsychotic Drugs
21: Neurodegenerative Disorders
The first edition of Psychopharmacology: Drugs, the Brain, and Behavior, published in 2004, was unique in its breadth of coverage ranging from historical accounts of drug use to clinical and preclinical behavioral studies to the latest research on drug effects in transgenic mouse models.
Student engagement with the material is fostered by opening each chapter with a relevant vignette and by providing breakout boxes presenting novel and, in some cases, controversial topics for special discussion. Box themes include History ofPsychopharmacology, Pharmacology in Action, Clinical Applications, and The Cutting Edge. The book is lavishly illustrated with full-color photographs and line art depicting important concepts and experimental data.
Psychopharmacology: Drugs, the Brain, and Behavior, Second Edition is appropriate for undergraduate or beginning level graduate courses in psychopharmacology or drugs and behavior that emphasize relationships between the behavioral effects of psychoactive drugs and their mechanisms of action.
• Introduces students to the study of drugs, the brain, and behavior
New to this Edition:
• A new and timely discussion of emerging substances of abuse such as Salvia divinorum, "spice" or "K2," and "bath salts"
• Presentation of key biological concepts such as epigenetics to help students understand current ideas about how mental illnesses arise and how drugs act on the brain to treat these illnesses
• Two new chapters that provide detailed information on various neurodegenerative disorders and the effects of neurotoxicants and endocrine disruptors on brain function and behavior
Jerrold S. Meyer, University of Massachusetts, Amherst, and Linda F. Quenzer, University of Hartford